Concepedia

Kaili Ding

KD

Statistics

Publications

2

Citations

87

H-Index

2

Active since

2010

Affiliations

Princess Margaret Cancer Centre(Current)

Kaili Ding is an author at Princess Margaret Cancer Centre specializing in cancer therapeutics, health sciences, and oncology.

Top concepts

HealthMedicineOncologyCancer TherapyClinical TrialsPharmacotherapyRadiation OncologyAgingGliomaPathology

Publications per year

2010–2014

2

Publications

2

A phase III randomized, double-blind, placebo-controlled trial of the epidermal growth factor receptor inhibitor gefitinb in completely resected stage IB-IIIA non-small cell lung cancer (NSCLC): NCIC CTG BR.19.

Glen Goss, Ian Lorimer, Ming‐Sound Tsao et al. · Journal of Clinical Oncology · 2010 · 76 citations

Surgical Oncology, Early Stage Nsclc, Cancer Management +17

A PHASE III RANDOMIZED CONTROLLED TRIAL OF SHORT-COURSE RADIOTHERAPY WITH OR WITHOUT CONCOMITANT AND ADJUVANT TEMOZOLOMIDE IN ELDERLY PATIENTS WITH GLIOBLASTOMA (NCIC CTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677)

Jan P, Chris J. O’Callaghan, Kaili Ding et al. · Neuro-Oncology · 2014 · 11 citations · Full text

Elderly Gbm, Aging, Elderly Patients +19

1–2 of 2